← Back to Clinical Trials
Recruiting NCT07244952

NCT07244952 Effects of Vojta Therapy on Posture and Trunk Control

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07244952
Status Recruiting
Phase
Sponsor University of Lahore
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 62 participants
Start Date 2025-11-15
Primary Completion 2026-08-15

Eligibility & Interventions

Sex All sexes
Min Age 45 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Vojta therapyRoutine physical therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 62 participants in total. It began in 2025-11-15 with a primary completion date of 2026-08-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Vojta therapy that is reflex locomotion therapy is a neurophysiological rehabilitation approach that stimulates specific "reflex zones" on the body to activate global, innate movement patterns. In stroke rehabilitation, it is used to improve postural control, trunk stability, and functional movement by engaging automatic motor responses. Vojta stimulation can activate motor cortical and subcortical areas as well as postural muscles. Pose estimation will be used to analyze human motion in stroke patients. The study will identify if there is significant difference in the comparative effects of Vojta therapy in addition to routine physical therapy on posture, trunk control and upper extremity motor function in sub-acute stroke patients

Eligibility Criteria

Inclusion Criteria: * Age 45-65 years * Both males and females * First time subacute stroke (7 days post stroke to 3 months) * Brunnstrom stage 1,2 * A confirmed CT scan for subacute ischemic stroke * A hemiplegia with score of ≤2 of medical research council scale for muscle strength of the arm (MRCS) * Premorbid modified Rankin scale score ≤ 3 * Stroke patient who can achieve supported standing * Patients having NIHSS score 16-20 will be included * Patient who can achieve sitting for 30 seconds Exclusion Criteria: * Severe cognitive impairments that can hinder rehabilitation * Limitations in communication due to aphasia * Altered consciousness or dementia (Epple et al., 2020b) * Patients suffering from postural hypotension

Contact & Investigator

Central Contact

Wajeeha Mahmood, BSPT,PPDPT,MSNMPT

✉ 70137173@student.uol.edu.pk

📞 03349867317

Frequently Asked Questions

Who can join the NCT07244952 clinical trial?

This trial is open to participants of all sexes, aged 45 Years or older, up to 65 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07244952 currently recruiting?

Yes, NCT07244952 is actively recruiting participants. Contact the research team at 70137173@student.uol.edu.pk for enrollment information.

Where is the NCT07244952 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT07244952 clinical trial?

NCT07244952 is sponsored by University of Lahore. The trial plans to enroll 62 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology